Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,078
archived clinical trials in
Major Depression Disorder (MDD)

Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  12/17/2013
Clinical Research Facility
1290
mi
from
New York, NY
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/17/2013
Clinical Research Facility
1290
mi
from
New York, NY
Click here to add this to my saved trials
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  12/17/2013
Clinical Research Facility
1282
mi
from
Staten Island, NY
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/17/2013
Clinical Research Facility
1282
mi
from
Staten Island, NY
Click here to add this to my saved trials
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  12/17/2013
Clinical Research Facility
1383
mi
from
Portland, OR
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/17/2013
Clinical Research Facility
1383
mi
from
Portland, OR
Click here to add this to my saved trials
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  12/17/2013
Clinical Research Facility
793
mi
from
Clinton, UT
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/17/2013
Clinical Research Facility
793
mi
from
Clinton, UT
Click here to add this to my saved trials
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  12/17/2013
Clinical Research Facility
1402
mi
from
Bellevue, WA
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
8-Week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of LY2940094 Administered Once Daily in Patients With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/17/2013
Clinical Research Facility
1402
mi
from
Bellevue, WA
Click here to add this to my saved trials
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated:  12/17/2013
Johns Hopkins University
1148
mi
from
Baltimore, MD
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated: 12/17/2013
Johns Hopkins University
1148
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated:  12/17/2013
University of Maryland
1148
mi
from
Baltimore, MD
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated: 12/17/2013
University of Maryland
1148
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated:  12/17/2013
The Zucker Hillside Hospital
1302
mi
from
Glen Oaks, NY
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated: 12/17/2013
The Zucker Hillside Hospital
1302
mi
from
Glen Oaks, NY
Click here to add this to my saved trials
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated:  12/17/2013
Univ of North Carolina
1043
mi
from
Chapel Hill, NC
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Status: Enrolling
Updated: 12/17/2013
Univ of North Carolina
1043
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Problem-Solving Therapy for People With Major Depression and Chronic Obstructive Pulmonary Disease
Treating Older Patients With Major Depression and Severe COPD
Status: Enrolling
Updated:  12/19/2013
The Burke Rehabilitation Hospital
1300
mi
from
White Plains, NY
Problem-Solving Therapy for People With Major Depression and Chronic Obstructive Pulmonary Disease
Treating Older Patients With Major Depression and Severe COPD
Status: Enrolling
Updated: 12/19/2013
The Burke Rehabilitation Hospital
1300
mi
from
White Plains, NY
Click here to add this to my saved trials
Problem-Solving Therapy for People With Major Depression and Chronic Obstructive Pulmonary Disease
Treating Older Patients With Major Depression and Severe COPD
Status: Enrolling
Updated:  12/19/2013
Weill Medical College of Cornell University
1301
mi
from
White Plains, NY
Problem-Solving Therapy for People With Major Depression and Chronic Obstructive Pulmonary Disease
Treating Older Patients With Major Depression and Severe COPD
Status: Enrolling
Updated: 12/19/2013
Weill Medical College of Cornell University
1301
mi
from
White Plains, NY
Click here to add this to my saved trials
Intranasal Ketamine in Treatment-Resistant Depression
Intranasal (IN) Ketamine in Treatment-Resistant Depression (TRD)
Status: Enrolling
Updated:  12/19/2013
Icahn School of Medicine at Mount Sinai
1290
mi
from
New York City, NY
Intranasal Ketamine in Treatment-Resistant Depression
Intranasal (IN) Ketamine in Treatment-Resistant Depression (TRD)
Status: Enrolling
Updated: 12/19/2013
Icahn School of Medicine at Mount Sinai
1290
mi
from
New York City, NY
Click here to add this to my saved trials
The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar Depressives
The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar Depressives
Status: Enrolling
Updated:  1/3/2014
Massachusetts General Hospital
1443
mi
from
Boston, MA
The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar Depressives
The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar Depressives
Status: Enrolling
Updated: 1/3/2014
Massachusetts General Hospital
1443
mi
from
Boston, MA
Click here to add this to my saved trials
Light Therapy for Bipolar Disorder. Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial
Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial
Status: Enrolling
Updated:  1/24/2014
University of Pittsburgh
973
mi
from
Pittsburgh, PA
Light Therapy for Bipolar Disorder. Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial
Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial
Status: Enrolling
Updated: 1/24/2014
University of Pittsburgh
973
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Light Therapy for Bipolar Disorder. Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial
Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial
Status: Enrolling
Updated:  1/24/2014
University of Pittsburgh, Western Psychiatric Institute and Clinic
974
mi
from
Pittsburgh, PA
Light Therapy for Bipolar Disorder. Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial
Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial
Status: Enrolling
Updated: 1/24/2014
University of Pittsburgh, Western Psychiatric Institute and Clinic
974
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Comparison of Cognitive and Dynamic Therapy for Depression in Community Settings
A Comparison of Cognitive and Dynamic Therapy for MDD in Community Settings
Status: Enrolling
Updated:  2/14/2014
Univ of Pennsylvania
1223
mi
from
Philadelphia, PA
A Comparison of Cognitive and Dynamic Therapy for Depression in Community Settings
A Comparison of Cognitive and Dynamic Therapy for MDD in Community Settings
Status: Enrolling
Updated: 2/14/2014
Univ of Pennsylvania
1223
mi
from
Philadelphia, PA
Click here to add this to my saved trials
An Open Label Study of the Genecept™ Assay in Treatment Resistant Depression
An Open Label Study of the Genecept™ Assay to Evaluate Efficacy of Using Assay Guided Treatment in Outpatient Adults With Treatment Resistant Depression
Status: Enrolling
Updated:  2/19/2014
Genomind, LLC
1223
mi
from
Chalfont, PA
An Open Label Study of the Genecept™ Assay in Treatment Resistant Depression
An Open Label Study of the Genecept™ Assay to Evaluate Efficacy of Using Assay Guided Treatment in Outpatient Adults With Treatment Resistant Depression
Status: Enrolling
Updated: 2/19/2014
Genomind, LLC
1223
mi
from
Chalfont, PA
Click here to add this to my saved trials
Adjunctive Mixed Salts Amphetamine (MSA) for Depressed Adults With Incomplete Response to Current Antidepressant Therapy (ADT)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Adjunctive, Flexible-Dose Mixed Salts Amphetamine (MSA) in Adult Outpatients With Major Depressive Disorder (MDD) Responding Inadequately to Current Antidepressant Therapy (ADT)
Status: Enrolling
Updated:  3/17/2014
Rush University Medical Center
608
mi
from
Chicago, IL
Adjunctive Mixed Salts Amphetamine (MSA) for Depressed Adults With Incomplete Response to Current Antidepressant Therapy (ADT)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Adjunctive, Flexible-Dose Mixed Salts Amphetamine (MSA) in Adult Outpatients With Major Depressive Disorder (MDD) Responding Inadequately to Current Antidepressant Therapy (ADT)
Status: Enrolling
Updated: 3/17/2014
Rush University Medical Center
608
mi
from
Chicago, IL
Click here to add this to my saved trials
Mobile Technology to Engage and Link Patients and Providers in Antidepressant Treatment
Mobile Technology to Engage and Link Patients and Providers in Antidepressant Treatment
Status: Enrolling
Updated:  3/24/2014
Northwestern University
611
mi
from
Chicago, IL
Mobile Technology to Engage and Link Patients and Providers in Antidepressant Treatment
Mobile Technology to Engage and Link Patients and Providers in Antidepressant Treatment
Status: Enrolling
Updated: 3/24/2014
Northwestern University
611
mi
from
Chicago, IL
Click here to add this to my saved trials
Neuronal Responses to Social Feedback in Major Depressive Disorder
Neuronal Responses to Social Feedback in Major Depressive Disorder
Status: Enrolling
Updated:  7/11/2014
University of Michigan
808
mi
from
Ann Arbor, MI
Neuronal Responses to Social Feedback in Major Depressive Disorder
Neuronal Responses to Social Feedback in Major Depressive Disorder
Status: Enrolling
Updated: 7/11/2014
University of Michigan
808
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Comparison of Medication Augmentation and PST in the Treatment of Depression in Older Adults
A Comparison of Medication Augmentation and Problem Solving Therapy
Status: Enrolling
Updated:  8/14/2014
New York State Psychiatric Institute
1290
mi
from
New York, NY
A Comparison of Medication Augmentation and PST in the Treatment of Depression in Older Adults
A Comparison of Medication Augmentation and Problem Solving Therapy
Status: Enrolling
Updated: 8/14/2014
New York State Psychiatric Institute
1290
mi
from
New York, NY
Click here to add this to my saved trials
Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression
Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression
Status: Enrolling
Updated:  8/20/2014
New York State Psychiatric Institute, 1051 Riverside Drive
1286
mi
from
New York, NY
Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression
Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression
Status: Enrolling
Updated: 8/20/2014
New York State Psychiatric Institute, 1051 Riverside Drive
1286
mi
from
New York, NY
Click here to add this to my saved trials
Identifying Biological Markers for Severe Depression
Identifying Biological Markers for Severe Depression
Status: Enrolling
Updated:  8/21/2014
University of California, Irvine
1152
mi
from
Irvine, CA
Identifying Biological Markers for Severe Depression
Identifying Biological Markers for Severe Depression
Status: Enrolling
Updated: 8/21/2014
University of California, Irvine
1152
mi
from
Irvine, CA
Click here to add this to my saved trials
Identifying Biological Markers for Severe Depression
Identifying Biological Markers for Severe Depression
Status: Enrolling
Updated:  8/21/2014
Stanford University, Department of Psychiatry and Behavioral Sciences
1329
mi
from
Stanford, CA
Identifying Biological Markers for Severe Depression
Identifying Biological Markers for Severe Depression
Status: Enrolling
Updated: 8/21/2014
Stanford University, Department of Psychiatry and Behavioral Sciences
1329
mi
from
Stanford, CA
Click here to add this to my saved trials
Identifying Biological Markers for Severe Depression
Identifying Biological Markers for Severe Depression
Status: Enrolling
Updated:  8/21/2014
Weill-Cornell Medical College
1289
mi
from
New York, NY
Identifying Biological Markers for Severe Depression
Identifying Biological Markers for Severe Depression
Status: Enrolling
Updated: 8/21/2014
Weill-Cornell Medical College
1289
mi
from
New York, NY
Click here to add this to my saved trials
Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and Irritability
A Placebo-Controlled Crossover Study of Iloperidone Augmentation of SSRIs for Residual Anger and Irritability in Major Depressive Disorder
Status: Enrolling
Updated:  11/4/2014
Massachusetts General Hospital
1443
mi
from
Boston, MA
Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and Irritability
A Placebo-Controlled Crossover Study of Iloperidone Augmentation of SSRIs for Residual Anger and Irritability in Major Depressive Disorder
Status: Enrolling
Updated: 11/4/2014
Massachusetts General Hospital
1443
mi
from
Boston, MA
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
1165
mi
from
Glendale, CA
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
1165
mi
from
Glendale, CA
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
1140
mi
from
National City, CA
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
1140
mi
from
National City, CA
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
1130
mi
from
Riverside, CA
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
1130
mi
from
Riverside, CA
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
1143
mi
from
San Diego, CA
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
1143
mi
from
San Diego, CA
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
1204
mi
from
Fort Meyers, FL
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
1204
mi
from
Fort Meyers, FL
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
1320
mi
from
Miami, FL
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
1320
mi
from
Miami, FL
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
1140
mi
from
Winter Park, FL
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
1140
mi
from
Winter Park, FL
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
801
mi
from
Atlanta, GA
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
801
mi
from
Atlanta, GA
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
791
mi
from
Smyrna, GA
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
791
mi
from
Smyrna, GA
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
608
mi
from
Libertyville, IL
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
608
mi
from
Libertyville, IL
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
594
mi
from
Schaumburg, IL
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
594
mi
from
Schaumburg, IL
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
1148
mi
from
Baltimore, MD
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
1148
mi
from
Baltimore, MD
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
574
mi
from
Flowood, MS
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
574
mi
from
Flowood, MS
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
1290
mi
from
New York, NY
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
1290
mi
from
New York, NY
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
903
mi
from
Beachwood, OH
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
903
mi
from
Beachwood, OH
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
726
mi
from
Cincinnati, OH
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
726
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
887
mi
from
Middleburg Heights, OH
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
887
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
1209
mi
from
Allentown, PA
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
1209
mi
from
Allentown, PA
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
1212
mi
from
Media, PA
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
1212
mi
from
Media, PA
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
1225
mi
from
Philadelphia, PA
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
1225
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
522
mi
from
Austin, TX
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
522
mi
from
Austin, TX
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
349
mi
from
Dallas, TX
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
349
mi
from
Dallas, TX
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
267
mi
from
Wichita Falls, TX
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
267
mi
from
Wichita Falls, TX
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
1407
mi
from
Kirkland, WA
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
1407
mi
from
Kirkland, WA
Click here to add this to my saved trials